652 related articles for article (PubMed ID: 15755578)
21. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
[TBL] [Abstract][Full Text] [Related]
22. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
Armstrong GL; Billah K; Rein DB; Hicks KA; Wirth KE; Bell BP
Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
[TBL] [Abstract][Full Text] [Related]
23. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
[TBL] [Abstract][Full Text] [Related]
24. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
Adang E; Voordijk L; Jan van der Wilt G; Ament A
Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
[TBL] [Abstract][Full Text] [Related]
26. Economic evaluation for ophthalmologists.
Kuper H; Jofre-Bonet M; Gilbert C
Ophthalmic Epidemiol; 2006 Dec; 13(6):393-401. PubMed ID: 17169853
[TBL] [Abstract][Full Text] [Related]
27. Methodological issues and new developments in the economic evaluation of vaccines.
Beutels P; Van Doorslaer E; Van Damme P; Hall J
Expert Rev Vaccines; 2003 Oct; 2(5):649-60. PubMed ID: 14711326
[TBL] [Abstract][Full Text] [Related]
28. Financing children's vaccines.
Nelson EA; Sack D; Wolfson L; Walker DG; Seng LF; Steele D
Vaccine; 2009 Nov; 27 Suppl 5():F12-7. PubMed ID: 19931710
[TBL] [Abstract][Full Text] [Related]
29. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
[TBL] [Abstract][Full Text] [Related]
30. [Health and economic benefits of compulsory regular vaccination in the Slovak Republic. I. Methods].
Hudecková H; Straka S
Epidemiol Mikrobiol Imunol; 2000 Feb; 49(1):24-7. PubMed ID: 10802948
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness analysis in oncology.
Evans WK
Praxis (Bern 1994); 2000 Mar; 89(12):492-6. PubMed ID: 10771589
[TBL] [Abstract][Full Text] [Related]
32. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
Patel MM; Parashar UD
J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
[TBL] [Abstract][Full Text] [Related]
33. Medical economics in the field of influenza--past, present and future.
Szucs TD
Virus Res; 2004 Jul; 103(1-2):25-30. PubMed ID: 15163484
[TBL] [Abstract][Full Text] [Related]
34. Economic evaluation in critical care medicine.
Cox HL; Laupland KB; Manns BJ
J Crit Care; 2006 Jun; 21(2):117-24. PubMed ID: 16769454
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
36. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
[TBL] [Abstract][Full Text] [Related]
37. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
Krauth C; John J; Aidelsburger P; Brüggenjürgen B; Hansmeier T; Hessel F; Kohlmann T; Moock J; Rothgang H; Schweikert B; Seitz R; Wasem J;
Gesundheitswesen; 2008 Jun; 70(6):e1-16. PubMed ID: 18661452
[TBL] [Abstract][Full Text] [Related]
38. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
39. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
40. The societal value of universal childhood vaccination.
Chabot I; Goetghebeur MM; Grégoire JP
Vaccine; 2004 May; 22(15-16):1992-2005. PubMed ID: 15121312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
